Penicillin Allergy Delabeling Program in Rehabilitation
Author Information
Author(s): Galipean Joseph Pharm.D., BCIDP, Jacob Jerry MD, MS
Primary Institution: Hospital of the University of Pennsylvania
Hypothesis
Can a penicillin allergy delabeling program improve antibiotic utilization and clinical outcomes in postacute inpatient rehabilitation settings?
Conclusion
The study supports the implementation of penicillin allergy delabeling programs in postacute care settings, suggesting that many patients mislabeled with a penicillin allergy can be safely delabeled.
Supporting Evidence
- 20% of patients were delabeled by history alone.
- 49% of patients did not meet eligibility criteria for penicillin allergy skin testing.
- Implementation of the program required minimal resources, only 2 pharmacist hours weekly.
- Updated guidelines recommend proactive efforts at penicillin allergy delabeling.
Takeaway
This study shows that many people who think they are allergic to penicillin might not be, and a program can help them safely use it again.
Methodology
A penicillin allergy delabeling program was implemented, involving patient interviews and skin testing to assess allergy status.
Potential Biases
Potential bias due to the absence of an allergist and reliance on conservative testing criteria.
Limitations
The program lacked an allergist and had conservative inclusion/exclusion criteria, which may have limited the number of patients delabeled.
Participant Demographics
Patients with reported penicillin allergies in an inpatient rehabilitation facility.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website